Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 1
1978 1
1981 1
1983 1
1986 2
1987 2
1988 5
1989 5
1990 7
1991 11
1992 9
1993 10
1994 21
1995 19
1996 15
1997 14
1998 15
1999 15
2000 19
2001 23
2002 19
2003 20
2004 36
2005 41
2006 51
2007 44
2008 47
2009 62
2010 57
2011 63
2012 66
2013 70
2014 55
2015 56
2016 78
2017 70
2018 75
2019 72
2020 87
2021 86
2022 80
2023 89
2024 88
2025 101
2026 76

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,577 results

Results by year

Filters applied: . Clear all
Page 1
Systemic sclerosis in adults. Part I: Clinical features and pathogenesis.
Jerjen R, Nikpour M, Krieg T, Denton CP, Saracino AM. Jerjen R, et al. J Am Acad Dermatol. 2022 Nov;87(5):937-954. doi: 10.1016/j.jaad.2021.10.065. Epub 2022 Feb 4. J Am Acad Dermatol. 2022. PMID: 35131402 Review.
Systemic sclerosis (SSc), also referred to as systemic scleroderma or scleroderma, is a rare, complex immune-mediated connective tissue disease characterized by progressive skin fibrosis and other clinically heterogenous features. ...Recent deve …
Systemic sclerosis (SSc), also referred to as systemic scleroderma or scleroderma, is a rare, complex imm …
Systemic sclerosis: one year in review 2024.
Lepri G, Di Battista M, Codullo V, Bonomi F, Sulis A, Guiducci S, Della Rossa A. Lepri G, et al. Clin Exp Rheumatol. 2024 Aug;42(8):1517-1528. doi: 10.55563/clinexprheumatol/is29he. Epub 2024 Jul 26. Clin Exp Rheumatol. 2024. PMID: 39058484 Free article. Review.
Systemic sclerosis (SSc) is a rare and chronic connective tissue disease of unknown aetiology and characterised by three main pathogenetic events represented by endothelial damage, inflammation with activation of the immune system leading to production of specific a …
Systemic sclerosis (SSc) is a rare and chronic connective tissue disease of unknown aetiology and characterised by three main …
Systemic sclerosis sine scleroderma.
Kucharz EJ, Kopeć-Mędrek M. Kucharz EJ, et al. Adv Clin Exp Med. 2017 Aug;26(5):875-880. doi: 10.17219/acem/64334. Adv Clin Exp Med. 2017. PMID: 29068586 Free article. Review.
Systemic sclerosis is a rare generalized disease with scleroderma, i.e. skin thickening as one of the most common symptoms. The disease has 2 main subsets, diffuse and limited forms. The subset known as systemic sclerosis sine sclerode …
Systemic sclerosis is a rare generalized disease with scleroderma, i.e. skin thickening as one of the most common sympt …
[Systemic sclerosis].
Faber AM, Krieg T, Hunzelmann N. Faber AM, et al. Dermatologie (Heidelb). 2024 Mar;75(3):181-196. doi: 10.1007/s00105-024-05298-8. Epub 2024 Feb 16. Dermatologie (Heidelb). 2024. PMID: 38366245 Review. German.
BACKGROUND: Systemic sclerosis (SSc) is a very heterogeneous, chronic, rare, but socioeconomically important disease with a severe disease course and severe impairment of the quality of life of affected patients. ...ACR/EULAR criteria allow the diagnosis of early fo …
BACKGROUND: Systemic sclerosis (SSc) is a very heterogeneous, chronic, rare, but socioeconomically important disease with a se …
Localized scleroderma: clinical spectrum and therapeutic update.
Careta MF, Romiti R. Careta MF, et al. An Bras Dermatol. 2015 Jan-Feb;90(1):62-73. doi: 10.1590/abd1806-4841.20152890. An Bras Dermatol. 2015. PMID: 25672301 Free PMC article. Review.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosi …
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic …
Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L. Ferreli C, et al. Clin Rev Allergy Immunol. 2017 Dec;53(3):306-336. doi: 10.1007/s12016-017-8625-4. Clin Rev Allergy Immunol. 2017. PMID: 28712039 Review.
Scleroderma refers to an autoimmune connective tissue fibrosing disease, including three different subsets: localized scleroderma, limited cutaneous systemic sclerosis, and diffuse cutaneous systemic sclerosis with di …
Scleroderma refers to an autoimmune connective tissue fibrosing disease, including three different subsets: localized scleroderma …
Pyoderma gangrenosum associated with limited cutaneous systemic sclerosis: a rare case with literature review.
Skopis M, Elghawy AA, Pociurko B, Oh KS, Bag-Ozbek A. Skopis M, et al. Clin Rheumatol. 2021 Mar;40(3):1141-1145. doi: 10.1007/s10067-020-05285-z. Epub 2020 Jul 16. Clin Rheumatol. 2021. PMID: 32676919 Review.
It is rarely associated with autoimmune disorders such as systemic sclerosis. We report a case of a patient with known limited cutaneous systemic sclerosis who developed an ulcerated lesion on the 2nd digit of the left hand. ...
It is rarely associated with autoimmune disorders such as systemic sclerosis. We report a case of a patient with known limi …
Juvenile systemic sclerosis.
Foeldvari I, Pain CE. Foeldvari I, et al. Best Pract Res Clin Rheumatol. 2026 May;40(2):102116. doi: 10.1016/j.berh.2026.102116. Epub 2026 Feb 3. Best Pract Res Clin Rheumatol. 2026. PMID: 41638996 Review.
Juvenile systemic sclerosis (jSSc) is a rare multisystem autoimmune disease, representing 4-10 % of systemic sclerosis (SSc) cases, and causes significant morbidity during growth and development. While sharing features with adult-onset disease, jSSc di …
Juvenile systemic sclerosis (jSSc) is a rare multisystem autoimmune disease, representing 4-10 % of systemic scleros …
Rethinking immunosuppression in limited cutaneous systemic sclerosis. The lcSSc conundrum; pros and cons for a timely immunosuppressive treatment.
Batani V, Del Galdo F, Matucci-Cerinic M, Allanore Y. Batani V, et al. Autoimmun Rev. 2026 Sep;25(9):104126. doi: 10.1016/j.autrev.2026.104126. Epub 2026 Jun 29. Autoimmun Rev. 2026. PMID: 42372841 Review.
The use of immunosuppressants (IS) has dramatically changed the management of autoimmune diseases. In systemic sclerosis (SSc), randomized controlled trials and international recommendations support IS use in patients with rapidly progressive diffuse disease or inte …
The use of immunosuppressants (IS) has dramatically changed the management of autoimmune diseases. In systemic sclerosis (SSc) …
1,577 results